Liquid based cytology and HPV DNA testing in a Greek population compared to colposcopy and histology

Clinical and Experimental Obstetrics and Gynecology

Volumn 40, Issue 1, 2013, Pages 131-136

  Diamantopoulou, S ^a   Spathis, A ^a   Chranioti, A ^a   Anninos, D ^a   Stamataki, M ^a   Chrelias, C ^a   Pappas, A ^a   Panayiotides, I ^a   Karakitsos, P ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Arrays; Cervix; Colposcopy; Histology; HPV DNA; Liquid based cytology

Indexed keywords

ADULT; AGED; ARTICLE; COLPOSCOPY; CROSS-SECTIONAL STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GREECE; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; INTERMETHOD COMPARISON; LIQUID BASED CYTOLOGY; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREVALENCE; SENSITIVITY ANALYSIS; SQUAMOUS CELL; SQUAMOUS EPITHELIUM; WART VIRUS;

ADOLESCENT; ADULT; AGED; COLPOSCOPY; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; GREECE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84876262353     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V. et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 12.
2. Agorastos T., Lambropoulos A.F., Sotiriadis A., Mikos T., Togaridou E., Emmanouilides C.J.: "Prevalence and distribution of high-risk human papillomavirus in Greece". Eur. J. Cancer Prev., 2009, 18, 504.
3. Cancer W.I.I.Co.H.a.C., Human Papillomavirus and Related Cancers in Greece, 2010.
4. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S. et al.: "Prevalence of HPV infection among females in the United States". JAMA, 2007, 297, 813.
5. Agorastos T., Dinas K., Lloveras B., Bosch F.X., Kornegay J.R., Bontis J.N. et al.: "Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece". Eur. J. Cancer Prev., 2004, 13, 145.
6. Kroupis C., Thomopoulou G., Papathomas T.G., Vourlidis N., Lazaris A.C.: "Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece". Epidemiol. Infect., 2007, 135, 943.
7. Panotopoulou E., Tserkezoglou A., Kouvousi M., Tsiaousi I., Chatzieleftheriou G., Daskalopoulou D. et al.: "Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women". J. Med. Virol., 2007, 79, 1898.
8. Stamataki P., Papazafiropoulou A., Elefsiniotis I., Giannakopoulou M., Brokalaki H., Apostolopoulou E. et al.: "Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic". BMC Infect. Dis., 2010, 10, 27.
9. Tsiodras S., Georgoulakis J., Chranioti A., Voulgaris Z., Psyrri A., Tsivilika A. et al.: "Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women". BMC Cancer, 2010, 10, 53.
10. Stoler M.H., Schiffman M.: "Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study". JAMA, 2001, 285, 1500.
11. Nobbenhuis M.A., Walboomers J.M., Heimerhorst T.J., Rozendaal L., Remmink A.J., Risse E.K. et al.: "Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study". Lancet, 1999, 354, 20.
12. Kulmala S.M., Syrjanen S., Shabalova I., Petrovichev N., Kozachenko V., Podistov J. et al.: "Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools". J. Clin. Microbiol., 2004, 42, 2470.
13. Yamazaki H., Sasagawa T., Basha W., Segawa T, Inoue M.: "Hybrid capture-II and LCR-E7 PCR assays for HPV typing in cervical cytologic samples". Int. J. Cancer, 2001, 94, 222.
14. Cuzick J., Beverley E., Ho L., Terry G., Sapper H., Mielzynska I. et al.: "HPV testing in primary screening of older women". Br. J. Cancer, 1999, 81, 554.
15. Riethmuller D., Gay C., Bertrand X., Bettinger D., Schaal J.P., Carbillet J.P. et al.: "Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction". Diagn. Mol. Pathol., 1999, 8, 157.
16. Meijer C.J., Snijders P.J., van den Brule A.J.: "Screening for cervical cancer: should we test for infection with high-risk HPV?". CMAJ, 2000, 163, 535.
17. Winer R.L., Kiviat N.B., Hughes J.P., Adam D.E., Lee S.K., Kuypers J.M. et al.: "Development and duration of human papillomavirus lesions, after initial infection". J. Infect. Dis., 2005, 191, 731.
18. Richart R.M., Masood S., Syrjanen K.J., Vassilakos P., Kaufman R.H., Meisels A. et al.: "Human papillomavirus". International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Acta Cytol., 1998, 42, 50.
19. Lorincz A.T., Richart R.M.: "Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs". Arch. Pathol. Lab. Med., 2003, 127, 959.
20. Kraus I., Molden T., Erno L.E., Skomedal H., Karlsen F., Hagmar B.: "Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones". Br. J. Cancer, 2004, 90, 1407.
21. Cox J.T., Lorincz A.T., Schiffman M.H., Sherman M.E., Cullen A., Kurman R.J.: "Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance". Am. J. Obstet. Gynecol., 1995, 172, 946.
22. Manos M.M., Kinney W.K., Hurley L.B., Sherman M.E., Shieh-Ngai J., Kurman R.J. et al.: "Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results". JAMA, 1999, 281, 1605.
23. Meijer C.J., van den Brule A.J., Snijders P.J., Helmerhorst T., Kenemans P., Walboomers J.M.: "Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening". IARC Sci. Publ., 1992, 271.
24. Clavel C., Masure M., Bory J.P., Putaud I., Mangeonjean C., Lorenzato M. et al.: "Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women". Br. J. Cancer, 1999, 80, 1306.
25. Cox J.T.: "Management of women with cervical cytology interpreted as ASC-US or as ASC-H". Clin. Obstet. Gynecol., 2005, 48, 160.
26. Alli P.M., Ali S.Z.: "Atypical squamous cells of undetermined significance-rule out high-grade squamous intraepithelial lesion: cytopathologic characteristics and clinical correlates". Diagn. Cytopathol., 2003, 28, 308.
27. Simsir A., Ioffe O., Sun P., Elgert P., Cangiarella J., Levine P.H.: "Effect of Bethesda 2001 on reporting of atypical squamous cells (ASC) with special emphasis on atypical squamous cells-cannot rule out high grade (ASC-H)". Diagn. Cytopathol., 2006, 34, 62.
28. Davey D.D., Neal M.H., Wilbur D.C., Colgan T.J., Styer P.E., Mody D.R.: "Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology". Arch. Pathol. Lab. Med., 2004, 128, 1224.
29. Solomon D., Schiffman M., Tarone R.: "Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial". J. Natl. Cancer Inst., 2001, 93, 293.
30. Sodhani P., Gupta S., Singh V., Sehgal A., Mitra A.B.: "Eliminating the diagnosis atypical squamous cells of undetermined significance: impact on the accuracy of the Papanicolaou test". Acta Cytol., 2004, 48, 783.
31. Yarandi F., Izadi Mood N., Mirashrafi F., Eftekhar Z.: "Colposcopic and histologic findings in women with a cytologic diagnosis of atypical squamous cells of undetermined significance". Aust. N Z J Obstet. Gynaecol., 2004, 44, 514.
32. Davey D.D., Naryshkin S., Nielsen M.L., Kline T.S.: "Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors". Diagn. Cytopathol., 1994, 11, 390.
33. Gerber S., De Grandi P., Petignat P., Mihaescu A., Delaloye J.F.: "Colposcopic evaluation after a repeat atypical squamous cells of undetermined significance (ASCUS) smear". Int. J. Gynaecol. Obstet., 2001, 75, 251.
34. Lee S.J., Jung K L., Lee J.W., Song S.Y., Kim B.G., Lee J.H. et al.: "Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management". Int. J. Gynecol. Cancer, 2006, 16, 664.
35. Juskevicius R., Zou K.H., Cibas E.S.: "An analysis of factors that influence the ASCUS/SIL ratio of pathologists". Am. J. Clin. Pathol., 2001, 116, 331.
36. Arbyn M., Sasieni P., Meijer C.J., Clavel C., Koliopoulos G., Dillner J.: "Clinical applications of HPV testing: a summary of meta-analyses". Vaccine, 2006, 24 (suppl. 3), S3/78.
37. Cox J.T., Schiffman M., Solomon D.: "Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy". Am. J. Obstet. Gynecol., 2003, 188, 1406.
38. Kaufman R.H., Adam E., Icenogle J., Reeves W.C.: "Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness". Am. J. Obstet. Gynecol., 1997, 177, 930.
39. Bergeron C., D. Jeannel, J. Poveda, P. Cassonnet, G. Orth: "Human papillomavirus testing in women with mild cytologic atypia". Obstet. Gynecol., 2000, 95, 821.
40. ASCUS-LSIL Triage Study (ALTS) Group, et al.: "Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance". Am. J. Obstet. Gynecol., 2003, 188, 1383.
41. Ferris D.G., T.C. Wright Jr., M.S. Litaker, R.M. Richart, A.T. Lorincz, X.W. Sun et al.: "Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL". J. Fam. Pract, 1998, 46, 136.
42. Wright T.C. Jr., A. Lorincz, D.G. Ferris, R.M. Richart, A. Ferenczy, I. Mielzynska et al.: "Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears". Am. J. Obstet. Gynecol., 1998, 178, 962.
43. Sherman M.E., D. Solomon, M. Schiffman: "Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study". Am. J. Clin. Pathol., 2001, 116, 386.
44. Arbyn M., P. Martin-Hirsch, F. Buntinx, M. Van Ranst, E. Paraskevaidis, J. Dillner: "Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate". J. Cell. Mol. Med., 2009, 13, 648.
45. Arbyn M., P. Martin-Hirsch, N. Wentzensen: "Human papillomavirus- based triage of women showing a cervical cytology result of borderline or mild dyskaryosis". BJOG, 2010, 117, 641.
46. Moscicki A.B., M. Schiffman, S. Kjaer, L.L. Villa: "Updating the natural history of HPV and anogenital cancer". Vaccine, 2006, 24 (suppl. 3), S3/42.
47. Ho G.Y., R. Bierman, L. Beardsley, C.J. Chang, R.D. Burk: "Natural history of cervicovaginal papillomavirus infection in young women". N. Engl. J. Med., 1998, 338, 423.
48. Mitchell M.F., D. Schottenfeld, G. Tortolero-Luna, S.B. Cantor, R. Richards-Kortum: "Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis". Obstet. Gynecol., 1998, 91, 626.
49. Hwang H.S., M. Park, S.Y. Lee, K.H. Kwon, M.G. Pang: "Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip". Cancer Epidemiol. Biomarkers Prev., 2004, 13, 2153.
50. Ho G.Y., A.S. Kadish, R.D. Burk, J. Basu, P.R. Palan, M. Mikhail et al.: "HPV16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia". Int. J. Cancer, 1998, 78, 281.
51. Wright T.C. Jr., J.T. Cox, L.S. Massad, J. Carlson, L.B. Twiggs, E.J. Wilkinson: "2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia". Am. J. Obstet. Gynecol., 2003, 189, 295.
52. Sahebali S., C.E. Depuydt, G.A. Boulet, M. Arbyn, L.M. Moeneclaey, A.J. Vereecken et al.: "Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study". Int. J. Cancer, 2006, 118, 1254.
53. Ferreccio C., M.C. Bratti, M.E. Sherman, R. Herrero, S. Wacholder, A. Hildesheim et al.: "A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer". Cancer Epidemiol. Biomarkers Prev., 2003, 12, 815.